Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY: DHR )

245.66 +1.48 (+0.61%)
Official Closing Price Updated: 7:00 PM EST, Jan 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Danaher Corp

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
17 18 Next >
CTLT Stock Sinks 25% After Catalent Delays Earnings Release
With embattled biotech firm Catalent delaying its earnings disclosure for one week, the severe loss of credibility hurt CTLT stock. 
Via InvestorPlace
Why Catalent Stock Is Tumbling Today
Catalent Inc (NASDAQ: CTLT) will be delaying the release of its third fiscal quarter results and investor conference call, previously scheduled for Tuesday,  
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
Via Benzinga
Analyst Ratings for Danaher
Via Benzinga
Credit Suisse Maintains Neutral Rating for Danaher: Here's What You Need To Know
Via Benzinga
Danaher Earnings Perspective: Return On Capital Employed
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Innovative Water Tech Stocks to Watch in a Thirsty World
The world is in need of water scarcity solutions. These water tech stocks are doing their part while offering upside potential for investors. 
Via InvestorPlace
7 Healthcare Stocks With Huge Return Potential for Long-Term Investors
These leading healthcare companies have proven that they can deliver reliable gains to their shareholders over many years and decades. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2023
Via Benzinga
Why Danaher Shares Are Falling Today
Via Benzinga
Looking At Danaher's Recent Unusual Options Activity
Via Benzinga
Here's How Much $100 Invested In Danaher 5 Years Ago Would Be Worth Today
Via Benzinga
Why Catalent Stock Tumbled by Nearly 6% on Tuesday
A warning about revenue and the abandonment of a potential suitor are recent developments that continue to hammer sentiment on the company. 
Via The Motley Fool
These 2 Large-Cap Laggards Are Leading Markets Lower Tuesday
Investors worry that an economic recession could hit entire swaths of the stock market hard. 
Via The Motley Fool
3 Healthcare Stocks With Huge Growth Potential
It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Catalent Stock Dove More Than 7% Today
The specialty healthcare company is having a miserable couple of days on the exchange. 
Via The Motley Fool
Why Catalent Shares Are Falling Today
Via Benzinga
Why Catalent Stock Slumped on Monday
It looks like the company won't be acquired after all...at least for now. 
Via The Motley Fool
What 5 Analyst Ratings Have To Say About Danaher
Via Benzinga
$100 Invested In Danaher 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
Via Benzinga
7 Stocks That Hedge Funds Are Dumping Now
Everyone loves talking about what institutional players are buying. On the flipside, here’s a list of hedge fund stocks to avoid. 
Via InvestorPlace
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,500 Today
Via Benzinga
Looking At Danaher's Recent Unusual Options Activity
Via Benzinga
3 Stocks to Buy for Life-Changing Wealth Potential
Investors hoping to succeed in the stock market should consider taking a position in these leading companies, each of which has outperformed. 
Via InvestorPlace
Etsy To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday
B of A Securities cut the price target for Stem, Inc. (NYSE: STEM) from $9 to $5. B of A Securities analyst Julien Dumoulin-Smith downgraded the stock from Neutral to Underperform. Stem shares fell... 
Via Benzinga
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch
These companies strive to bring down the cost of developing new therapies. 
Via The Motley Fool
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.